12:00 AM
 | 
Nov 12, 2012
 |  BC Week In Review  |  Company News  |  Deals

ExonHit, InGen BioSciences deal

ExonHit will acquire in vitro diagnostic company InGen for €18 million ($23 million) in a cash and stock deal. The resulting company will be named Diaxonhit. ExonHit will pay €8 million ($10.2 million) in cash and issue €10...

Read the full 168 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >